FDA Inspection 1221658 — Dr. Ajit Bapurao Nalawade
The FDA completed an inspection of Dr. Ajit Bapurao Nalawade on Oct 27, 2023 in Pune. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 27, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pune (India)
Additional Details
Clinical BA/BE
Citations
| ID | CFR | Description |
|---|---|---|
| 7534 | 21 CFR 312.68 | FDA access to clinical investigator records |